Accent Microcell Ltd. benchmarking: Perfomance to industry peers

Financial

	Accent Microcell	Anlon Healthcare	Anuh Pharma
Operational Metrics
Financials
5 yr Average ROE	19.21 %	35.86 %	15.87 %
5yr average Equity Multiplier	2.16	19.54	1.62
5yr Average Asset Turnover Ratio	1.47	0.72	1.35
5yr Avg Net Profit Margin	7.63 %	9.13 %	7.23 %
Price to Book	4.56	3.66	2.43
P/E	26.86	38.26	20.52
5yr Avg Cash Conversion Cycle	85.19 Days	215.12 Days	42.81 Days
Inventory Days	68.46 Days	146.25 Days	50.87 Days
Days Receivable	81.86 Days	172.55 Days	111.12 Days
Days Payable	72.23 Days	138.78 Days	117.6 Days
5yr Average Interest Coverage Ratio	34.73	3.68	48.66
5yr Avg ROCE	24.49 %	16.7 %	21.17 %
5yr Avg Operating Profit Margin	11.48 %	17.87 %	10.21 %
5 yr average Debt to Equity	0.49	13.59	0.02
5yr CAGR Net Profit	47.1 %	n/a	10.73 %
5yr Average Return on Assets	10.07 %	5.99 %	9.84 %
Shareholdings
Promoter Holding	55.44 %	52.68 %	71.82 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.35 %	0.0	1.23 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Accent Microcell	Anlon Healthcare	Anuh Pharma
Product Wise Break-Up	Product Wise Break-Up Nutraceuticals 0 Finished Dosage Formulation 0 APIs 0 Bulk drug and Chemicals 0 Others 100	Product Wise Break-Up Bulk drug and Chemicals 0 APIs 40.27 Nutraceuticals 6.61 Finished Dosage Formulation 53.12	Product Wise Break-Up Bulk drug and Chemicals 100.0 APIs 0 Nutraceuticals 0 Finished Dosage Formulation 0